Computational Medicinal Chemistry to Design Novel Phosphoinositide 3- Kinase (PI3K) Alpha Inhibitors in View of Cancer

E-ISSN： 1875-6646|10|3|147-157

ISSN： 1573-4072

Source： Current Bioactive Compounds, Vol.10, Iss.3, 2014-08, pp. : 147-157

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Small Molecule Inhibitors of Phosphoinositide 3-Kinase (PI3K) &dgr; and &ggr;

Current Topics in Medicinal Chemistry, Vol. 9, Iss. 8, 2009-05 ,pp. : 738-753

Bentham Science Publishers

Access to resources Recommend Favorite

Advances in the Development of Class I Phosphoinositide 3-Kinase (PI3K) Inhibitors

Current Topics in Medicinal Chemistry, Vol. 16, Iss. 13, 2016-05 ,pp. : 1413-1426

Bentham Science Publishers

Access to resources Recommend Favorite

Progress in the Preclinical Discovery and Clinical Development of Class I and Dual Class I/IV Phosphoinositide 3-Kinase (PI3K) Inhibitors

Current Medicinal Chemistry, Vol. 18, Iss. 18, 2011-06 ,pp. : 2686-2714

Bentham Science Publishers

Access to resources Recommend Favorite

PI-3-Kinase Inhibitors in Colorectal Cancer

Current Cancer Drug Targets, Vol. 11, Iss. 2, 2011-01 ,pp. : 190-198

Bentham Science Publishers

Access to resources Recommend Favorite

Novel inhibitors of the PI3K family

By Carnero Amancio

Expert Opinion on Investigational Drugs, Vol. 18, Iss. 9, 2009-09 ,pp. : 1265-1277

Informa Healthcare

Access to resources Recommend Favorite